Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis
Authors:
- 9 June 2021
- journal article
- research article
- Published by Springer Nature in Molecular Diversity
- Vol. 26 (2) , 1175-1190
Abstract
Traditional Chinese medicine (TCM) has exerted positive effects in controlling the COVID-19 pandemic. HuaShi XuanFei Formula (HSXFF) was developed to treat patients with mild and general COVID-19 in Zhejiang Province, China. The present study seeks to explore its potentially active compounds and pharmacological mechanisms against COVID-19 based on network pharmacology, molecular docking, and molecular dynamics (MD) simulation. All components of HSXFF were harvested from the pharmacology database of the TCMSP system. COVID-19-related targets were retrieved from using OMIM and GeneCards databases. The herb-compound-targets network was constructed by Cytoscape. The target protein–protein interaction (PPI) network, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) were performed to discover the potential key target genes and mechanism. The main active compounds of HSXFF were docked with 3C-like (3CL) protease hydrolase and angiotensin-converting enzyme 2 (ACE2). The MD simulation confirmed the binding stability of docking results. The herbs-targets network mainly contained 52 compounds and 70 corresponding targets, including key targets such as RELA, TNF, TP53, IL6, MAPK1, CXCL8, IL-1β, and MAPK14. The GO and KEGG indicated that HSXFF may be mainly acting on the IL-17 signaling pathway, TNF signaling pathway, NF-κB signaling pathway, etc. The molecular docking results indicated that isovitexin and procyanidin B1 showed the highest affinity with 3CL and ACE2, respectively, which were confirmed by MD simulation. These findings suggested HSXFF exerted therapeutic effects involving “multi-compounds and multi-targets.” It might be working through directly inhibiting the virus, improving immune function, and reducing the inflammatory in response to anti-COVID-19. In summary, the present study would provide a valuable direction for further research of HSXFF. Graphic abstractKeywords
Funding Information
- Ningbo City Science and Technology Innovation 2025 Major Research Project (2019B10008)
- Ningbo Natural Science Foundation Project (2019A610370,2017A610263)
- Zhejiang Province Public Welfare Technology Application Research Project (LGN18B020001,LGF20H280009)
- Natural Science Foundation of Zhejiang Province (LQ19C020003)
- The scientific research projects of Zhejiang Pharmaceutical College (XY2020003,2019010)
- Natural Science Foundation of Zhejiang Province (LQ19C020003)
- Ningbo Public Welfare Science and Technology Project (2019C50064)
- The Science and Technology Program of Fuzhou (2018-N-9)
This publication has 65 references indexed in Scilit:
- Network Pharmacology: A New Approach for Chinese Herbal Medicine ResearchEvidence-Based Complementary and Alternative Medicine, 2013
- The macrophage response towards LPS and its control through the p38MAPK–STAT3 axisCellular Signalling, 2012
- High-Throughput Screening for Anti–Influenza A Virus Drugs and Study of the Mechanism of Procyanidin on Influenza A Virus–Induced AutophagySLAS Discovery, 2012
- IL-17 Boosts Proinflammatory Outcome of Antiviral Response in Human CellsThe Journal of Immunology, 2011
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Human cytomegalovirus-inhibitory flavonoids: Studies on antiviral activity and mechanism of actionAntiviral Research, 2005
- Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8Science, 2004
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- GeneCards: integrating information about genes, proteins and diseasesTrends in Genetics, 1997